New HealthEquity Partnership Enhances Employee Access to Healthcare
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- S&P 500, Nasdaq hit record highs as Treasury yields stall, oil slips
- Oil prices fall nearly 2% as Middle East supply concerns ease
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
- Goldman flags 2 key market risks if a climb in yields persists
- Shell CEO says Middle East oil flows reach 80% of prewar levels
- HubSpot to cut 7% of workforce in restructuring plan
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Citi cuts investment banking analyst program to two years - Bloomberg
- Emera and Canadian Utilities agree to merge in $72B all-share deal
- Nasdaq notches record high close as investors focus on earnings
HealthEquity, Inc (HQY) PT Raised to $103 at Deutsche Bank
September 4, 2024 12:49 PM EDTDeutsche Bank analyst George Hill raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $103.00 (from $102.00) while maintaining a Buy rating.
The analyst comments "Solid Q2 Beat On Broad-based Strength: HQY reported another strong quarter with F2Q total revenue of $299.9 million coming in... More
HealthEquity, Inc (HQY) PT Lowered to $100 at BofA Securities
September 4, 2024 5:24 AM EDTBofA Securities analyst Allen Lutz lowered the price target on HealthEquity, Inc (NASDAQ: HQY) to $100.00 (from $105.00) while maintaining a Buy rating.
The analyst comments "Our Buy thesis for HealthEquity is predicated on faster than market organic growth, supplemented by portfolio M&A, and further enhanced by operating leverage. To date, the biggest driver of... More
HealthEquity, Inc (HQY) PT Raised to $110 at BTIG
September 4, 2024 5:10 AM EDTBTIG analyst David Larsen raised the price target on HealthEquity, Inc (NASDAQ: HQY) to $110.00 while maintaining a Buy rating.
The analyst comments "On Tuesday, 9/3/24 AMC, HQY reported excellent F2Q:25 results. Total revenue of $299.9M +23% y/y exceeded BTIG / consensus estimates of... More



